What is Esperion Therapeutics's change in AR?

Esperion Therapeutics (ESPR) reported change in AR of -$7.84M in Q1 2026.

How has Esperion Therapeutics's change in AR changed year-over-year?

Esperion Therapeutics's change in AR decreased by 780.4% year-over-year, from $1.15M to -$7.84M.

What is the long-term trend for Esperion Therapeutics's change in AR?

Over 4 years (2021 to 2025), Esperion Therapeutics's change in AR has grown at a 54.0% compound annual growth rate (CAGR), from $10.69M to $60.05M.

What does change in AR mean?

Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.

Esperion Therapeutics ESPR Change in AR

Change in AR at other companies

AmgenAMGN

-$413M-132%

Regeneron PharmaceuticalsREGN

-$1.2M+99.8%

Lexicon PharmaceuticalsLXRX

$9.4M+1,016%

Eton Pharmaceuticals, Inc.ETON

$1.65M-85.0%

BridgeBio PharmaBBIO

$65.78M-40.5%

Ultragenyx PharmaceuticalRARE

-$19M-90.0%

Other financials

Income statement

See full

Revenue$80.1M+23.2%

Operating income-$6.6M+70.2%

Net income-$25.2M+37.7%

EPS (diluted)-$0.10+52.4%

Balance sheet

See full

Cash & equivalents$156.2M+36.2%

Total debt$155.2M+6.1%

Total equity-$307.9M+27.8%

Total assets$462.5M+42.7%

Cash flow

See full

Operating cash flow-$27.7M-22.5%

CapEx$189.0K—

Free cash flow-$27.9M-23.3%

Valuation

See full

Market cap$811.73M+283%

Enterprise value$810.81M+233%

P/S1.9×+1.1×

Profitability

See full

Operating margin18.1%+12.7pp

Net margin-34.8%+8.0pp

FCF margin-30.7%—

Returns & leverage

See full

Return on equity-260.8%—

Debt / equity0.8×—

Current ratio1.5×+0.4×

Where this comes from

Reported directly by Esperion Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.

The official record: Esperion Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Esperion Therapeutics's change in ar.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Esperion Therapeutics's change in AR?: Esperion Therapeutics (ESPR) reported change in AR of -$7.84M in Q1 2026.
How has Esperion Therapeutics's change in AR changed year-over-year?: Esperion Therapeutics's change in AR decreased by 780.4% year-over-year, from $1.15M to -$7.84M.
What is the long-term trend for Esperion Therapeutics's change in AR?: Over 4 years (2021 to 2025), Esperion Therapeutics's change in AR has grown at a 54.0% compound annual growth rate (CAGR), from $10.69M to $60.05M.
What does change in AR mean?: Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.